Clinical Trial: Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease
Study Status: Completed
Recruit Status: RECRUITING
Condition: Sickle Cell Disease
Study Type: INTERVENTIONAL
Official Title: An Open-label Mechanistic Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Orally Administered Epeleuton in Patients With Sickle Cell Disease
Brief Summary:
To assess the pharmacokinetics, pharmacodynamics and safety of Epeleuton capsules in adult SCD patients who are aged ?18 years.
Read more